Cases & Deals

  • Home
  • Practices
  • TGR BioSciences executes patent strategy facilitating successful merger with Sygnis

Share

TGR BioSciences executes patent strategy facilitating successful merger with Sygnis

August 2018

Client(s) TGR BioSciences Pty Ltd

Jones Day developed and executed the patent strategy to support TGR BioSciences Pty Ltd's immunoassay technology in its merger with Sygnis AG.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.